Pfizer Ceo
- All
- News
- Videos
-
Trump Announces Pfizer Deal Offering Discounts On Medicines Via 'TrumpRx' Website
Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other drugmakers under the threat of tariffs.
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
-
EU Chief Slammed For Secret Texts To Pfizer CEO, Ordered To Turn Them In
An official EU watchdog on Friday slammed European Commission chief Ursula von der Leyen for keeping secret text messages with Pfizer's CEO about purchasing Covid vaccine doses, saying it "constituted maladministration".
-
Pfizer Says "Already Working" On Vaccine Targeting 'Omicron' Variant
Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the 'Omicron' variant in case the current inoculation is not effective against the new strain, the US drugmaker's CEO Albert Bourla said Monday.
-
Pfizer In "Final Stages" Of Approval For Covid Vaccine In India: CEO
Pfizer CEO Albert Bourla has said that his company hope to finalise a deal with the Indian government on the approval for the company's Covid vaccine. A few days ago, NITI Aayog member D VK Paul, too, had said the same thing.
-
Pfizer CEO Says In Final Stages To Get Approval For COVID-19 Vaccine In India: Report
"I hope very soon we will finalise an agreement with the government," said Pfizer's CEO Albert Bourla
-
Pfizer CEO "Not At All" In Favour Of US Patent Waiver: Report
Pfizer CEO Albert Bourla on Thursday said he was against a US-backed proposal to waive patents on Covid-19 vaccines, saying production should be ramped up in existing facilities instead.
-
Pfizer In Talks With India Over "Expedited Approval" For COVID-19 Vaccine
Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
-
"Strengthen Pandemic Response": Indian Envoy's Meet With Pfizer CEO In US
Indian Ambassador to the USTaranjit Singh Sandhu on Thursday (local time) met with Pfizer CEO Albert Bouria to discuss ways in which the COVID-19 vaccine maker can support healthcare efforts in India.
-
Trump Announces Pfizer Deal Offering Discounts On Medicines Via 'TrumpRx' Website
Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other drugmakers under the threat of tariffs.
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
-
EU Chief Slammed For Secret Texts To Pfizer CEO, Ordered To Turn Them In
An official EU watchdog on Friday slammed European Commission chief Ursula von der Leyen for keeping secret text messages with Pfizer's CEO about purchasing Covid vaccine doses, saying it "constituted maladministration".
-
Pfizer Says "Already Working" On Vaccine Targeting 'Omicron' Variant
Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the 'Omicron' variant in case the current inoculation is not effective against the new strain, the US drugmaker's CEO Albert Bourla said Monday.
-
Pfizer In "Final Stages" Of Approval For Covid Vaccine In India: CEO
Pfizer CEO Albert Bourla has said that his company hope to finalise a deal with the Indian government on the approval for the company's Covid vaccine. A few days ago, NITI Aayog member D VK Paul, too, had said the same thing.
-
Pfizer CEO Says In Final Stages To Get Approval For COVID-19 Vaccine In India: Report
"I hope very soon we will finalise an agreement with the government," said Pfizer's CEO Albert Bourla
-
Pfizer CEO "Not At All" In Favour Of US Patent Waiver: Report
Pfizer CEO Albert Bourla on Thursday said he was against a US-backed proposal to waive patents on Covid-19 vaccines, saying production should be ramped up in existing facilities instead.
-
Pfizer In Talks With India Over "Expedited Approval" For COVID-19 Vaccine
Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
-
"Strengthen Pandemic Response": Indian Envoy's Meet With Pfizer CEO In US
Indian Ambassador to the USTaranjit Singh Sandhu on Thursday (local time) met with Pfizer CEO Albert Bouria to discuss ways in which the COVID-19 vaccine maker can support healthcare efforts in India.
